ArticleScientific reports2026
Radiation dose has no significant impact on CT-based bone mineral density measurements in a large-animal model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone mineral density (BMD) is a biomarker for frailty, and CT-derived radiodensity can be extracted fully automatically as a surrogate. Because these measurements might be affected by image noise, which varies substantially in the clinical routine, this systematic large-animal study investigates the consistency of CT-based BMD measurements under different radiation dose settings. Twenty Göttingen minipigs underwent six non-contrast CT examinations with five dose levels (CTDIvol: 0.53-10.01 mGy; 5%, 10%, 20%, 40%, 100%; 600 scans). BMD was assessed using CT-derived radiodensity (Hounsfield units, HU) by segmenting the complete ninth thoracic vertebra, and by placing a region of interest (ROI) in the trabecular bone. RM-ANOVA was used to assess statistical significance. Data are presented as mean with standard deviation. The BMD measurement remained consistent between the control and the different dose settings. Even the lowest dose setting (5%: complete = 761 [± 56] HU, ROI = 749 [± 72] HU) showed no significant differences compared to the control (complete = 756 [± 55] HU, ROI = 738 [± 68] HU). Finally, CT-based BMD measurements remained consistent and are therefore robust to substantial dose reduction, indicating the technical feasibility of comparing CT examinations with different dose protocols, relevant for opportunistic screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.